{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T01:16:22Z","timestamp":1784337382643,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T00:00:00Z","timestamp":1521590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12969-018-0235-z","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T04:05:26Z","timestamp":1522814726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey"],"prefix":"10.1186","volume":"16","author":[{"given":"Jerold","family":"Jeyaratnam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke M.","family":"ter Haar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen J.","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Kasapcopur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.","family":"Ombrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Dedeoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi H.","family":"Baris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan J.","family":"Vastert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico M.","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,21]]},"reference":[{"key":"235_CR1","unstructured":"John M, Davey S. State of the world\u2019s vaccines and immunization. Third. Executive summary 2009. URL: http:\/\/apps.who.int\/iris\/bitstream\/10665\/70114\/1\/WHO_IVB_09.10_eng.pdf Accessed 27 Nov 2015."},{"issue":"5","key":"235_CR2","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","volume":"72","author":"N ter Haar","year":"2013","unstructured":"ter Haar N, Lachmann H, \u00d6zen S, Woo P, Uziel Y, Modesto C, et al. Treatment of autoinflammatory diseases: results from the Eurofever registry and a literature review. Ann Rheum Dis. 2013;72(5):678\u201385.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"235_CR3","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/ard.2011.150193","volume":"70","author":"MW Heijstek","year":"2011","unstructured":"Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, van der Klis F, Kone-Paut I, et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis. 2011;70(10):1704\u201312.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"235_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1136\/ard.2010.137216","volume":"70","author":"S van Assen","year":"2011","unstructured":"van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011;70(3):414\u201322.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"235_CR5","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","volume":"74","author":"NM ter Haar","year":"2015","unstructured":"ter Haar NM, Oswald M, Jeyaratnam J, Anton J, Barron KS, Brogan PA, et al. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis. 2015;74(9):1636\u201344.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"235_CR6","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002;46(9):2287\u201393.","journal-title":"Arthritis Rheum"},{"key":"235_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1053\/berh.2001.0226","volume":"16","author":"BJ Fessler","year":"2002","unstructured":"Fessler BJ. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol. 2002;16:281\u201391.4.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"235_CR8","volume-title":"Reporting adverse drug reactions","author":"Z Bankowski","year":"1999","unstructured":"Bankowski Z, Bruppacher R, Crusius I, Gallagher J, Kremer G, Venulet J. Reporting adverse drug reactions. Geneva: Councel for International Organizations of Medical Scientists; 1999."},{"issue":"RR06","key":"235_CR9","first-page":"1","volume":"48","author":"CDC","year":"1999","unstructured":"CDC. Prevention of varicella updated recommendations of the advisory committee on immunization practices (ACIP). MMWR. 1999;48(RR06):1\u20135.","journal-title":"MMWR"},{"issue":"11","key":"235_CR10","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1002\/art.39763","volume":"68","author":"NM Ter Haar","year":"2016","unstructured":"Ter Haar NM, Jeyaratnam J, Lachmann HJ, Simon A, Brogan PA, Doglio M, et al. The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever registry. Arthritis Rheum. 2016;68(11):2795\u2013805.","journal-title":"Arthritis Rheum"},{"key":"235_CR11","volume-title":"Understanding MMR vaccine safety","author":"CDC","year":"2013","unstructured":"CDC. Understanding MMR vaccine safety. 2013. URL: https:\/\/www.cdc.gov\/vaccines\/hcp\/patient-ed\/conversations\/downloads\/vacsafe-mmr-color-office.pdf ."},{"issue":"12","key":"235_CR12","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1128\/CVI.00175-10","volume":"17","author":"A Chioato","year":"2010","unstructured":"Chioato A, Noseda E, Felix SD, Stevens M, Del Giudice G, Fitoussi S, et al. Influenza and meningococcal vaccinations are effective in healthy subjects treated with the interleukin-1 beta-blocking antibody canakinumab: results of an open-label, parallel group, randomized, single-center study. Clin Vaccine Immunol. 2010;17(12):1952\u20137.","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl 1","key":"235_CR13","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1186\/1546-0096-13-S1-P1","volume":"13","author":"P Brogan","year":"2015","unstructured":"Brogan P, Hofer M, Kuemmerle-Deschner J, et al. Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab. Pediatr Rheumatol. 2015;13(Suppl 1):P1.","journal-title":"Pediatr Rheumatol"},{"issue":"5","key":"235_CR14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/ard.2010.134254","volume":"70","author":"P Quartier","year":"2011","unstructured":"Quartier P, Allantaz F, Cimaz R, Pillet P, Messiaen C, Bardin C, et al. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis. 2011;70(5):747\u201354.","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"235_CR15","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1001\/jama.2013.6768","volume":"309","author":"MW Heijstek","year":"2013","unstructured":"Heijstek MW, Kamphuis S, Armbrust W, Swart J, Gorter S, de Vries LD, et al. Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial. JAMA. 2013;309(23):2449\u201356.","journal-title":"JAMA"},{"issue":"12","key":"235_CR16","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1136\/ard.2011.152728","volume":"70","author":"JB Kuemmerle-Deschner","year":"2011","unstructured":"Kuemmerle-Deschner JB, Hachulla E, Cartwright R, Hawkins PN, Tran TA, Bader-Meunier B, et al. Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes. Ann Rheum Dis. 2011;70(12):2095\u2013102.","journal-title":"Ann Rheum Dis"},{"key":"235_CR17","doi-asserted-by":"crossref","unstructured":"Jaeger VK, Hoffman HM, van der Poll T, Tilson H, Seibert J, Speziale A, et al. Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study. Rheumatology (Oxford) 2017;56(9):1484\u201391.","DOI":"10.1093\/rheumatology\/kex185"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0235-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12969-018-0235-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-018-0235-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T02:04:21Z","timestamp":1571018661000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-018-0235-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,21]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["235"],"URL":"https:\/\/doi.org\/10.1186\/s12969-018-0235-z","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,21]]},"assertion":[{"value":"3 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained by the institutional ethical committee in accordance with local ethical regulations; the study was conducted in accordance with the ethical principles of the declaration of Helsinki. Written informed consent was obtained from the patient or the legal guardians in case of minors according to local requirements.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"19"}}